Pulley Pharmaceuticals: An indicative announcement on anticipating that convertible debt-to-equity conversion prices will trigger downward correction conditions
May 10, 2023 07:35 ET
Pulley Pharmaceuticals: An indicative announcement on anticipating that convertible debt-to-equity conversion prices will trigger downward correction conditions
Dec 2, 2022 04:28 ET
Pulley Pharmaceuticals: 2021 Annual Equity Distribution Implementation Notice
Jul 5, 2022 12:00 ET
Pulley Pharmaceutical: 2021 Hainan Puli Pharmaceutical Co., Ltd. issued convertible corporate bonds to unspecified targets 2022 tracking rating report
Jun 17, 2022 07:30 ET
Pulley Pharmaceuticals: Announcement on 2022 interest payments on convertible corporate bonds
Jan 25, 2022 11:00 ET
Pulley Pharmaceuticals: Announcement on the reduction of convertible corporate bond holdings by controlling shareholders and co-actors
Nov 5, 2021 05:09 ET
Pulley Pharmaceuticals: Announcement on the reduction of convertible corporate bond holdings by controlling shareholders and co-actors
Nov 1, 2021 05:43 ET
Pulley Pharmaceuticals: Announcement on the controlling shareholder's holdings of convertible corporate bonds
Sep 24, 2021 07:15 ET
Pulley Pharmaceuticals: Announcement on price adjustments for convertible corporate bonds to shares
Jul 1, 2021 12:00 ET
Pulley Pharmaceuticals: Online Roadshow Announcement on Issuance of Convertible Corporate Bonds to Unspecified Targets
Feb 4, 2021 11:00 ET
Pulley Pharmaceuticals: Responses from issuers and sponsors to the review enquiry letter (updated version of the 2020 Third Quarter Report)
Dec 14, 2020 11:00 ET
Pulley Pharmaceuticals: Accountant's Response to the Audit Inquiry Letter (2020 Third Quarterly Report Updated Draft)
Dec 14, 2020 11:00 ET
Pulley Pharmaceuticals: Supplemental Legal Opinion (2)
Dec 14, 2020 11:00 ET
Pulley Pharmaceuticals: Accountant's Response to the Listing Committee's Review and Implementation Letter
Nov 30, 2020 11:00 ET
Pulley Pharmaceuticals: Responses from issuers and sponsors to the implementation letter of the Listing Committee's review opinions
Nov 30, 2020 11:00 ET
Pulley Pharmaceuticals: Announcement on the application for issuing convertible corporate bonds to unspecified targets and approved by the Shenzhen Stock Exchange GEM Listing Committee
Nov 26, 2020 02:58 ET
Pulley Pharmaceutical: Implementation letter on the review opinions of the listing committee of Hainan Puli Pharmaceutical Co., Ltd.
Nov 25, 2020 11:00 ET
Pulley Pharmaceuticals: Response of the Company and Haitong Securities Co., Ltd. to the audit inquiry letter on the company's application to issue convertible corporate bonds to unspecified targets
Nov 2, 2020 11:00 ET
Pulley Pharmaceuticals: Accountant's Response to the Audit Enquiry Letter
Nov 1, 2020 11:00 ET
Pulley Pharmaceuticals: Supplemental Legal Opinion (1)
Nov 1, 2020 11:00 ET
No Data
No Data